Fierce Healthcare March 26, 2024
It’s Groundhog Day for Medicare Part B drug manufacturers.
On Tuesday, the Department of Health and Human Services (HHS) dropped its latest list of drugs capped by inflation rebates. From April 1 to June 30, 41 drugs that will have a lower coinsurance rate if a drug company raises prices quicker than the rate of inflation.
Expected to impact nearly three-quarters of a million people, some people could save up to $3,575 per average dose through the Medicare Prescription Drug Inflation Rebate Program, according to a news release.
“Thanks to President Biden’s lower cost prescription drug law, the cost of prescription drugs is coming down for people with Medicare. We are putting money back in the pockets...
Today's Sponsors
Today's Sponsor
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech